https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Thus, liver surface nodularity could be an option for the preoperative detection of clinically significant portal hypertension in patients with hepatocellular carcinoma. Combining liver surface nodularity with LSM-spleen-size-to-platelet ratio score resulted in the accurate detection of clinically significant portal hypertension in 75% of patients, thus limiting the need for HVPG measurements. 75% of patients, thus limiting the need for HVPG measurements. To date, there is only scare evidence characterizing the temporal features a
Like
Comment
Share
